IndraLab

Statements


EGFR-vIII mutation inhibits USP11. 3 / 3
| 3

eidos
"Conclusions : EGFR-vIII mutation downregulates H2AZK4 / 7AC and H3K27AC , inhibiting USP11 expression though the PI3K / AKT-HDAC1 / 2 axis ."

eidos
"EGFR-vIII mutation can downregulate H2AZK4 / 7AC and H3K27AC , inhibiting USP11 expression though the PI3K / AKT-HDAC1 / 2 axis ."

eidos
"We demonstrated that the EGFR-vIII mutation downregulated H2AZK4 / 7AC and H3K27AC , inhibiting USP11 expression though the PI3K / AKT-HDAC1 / 2 axis ."